STOCKHOLM, Aug. 5, 2024
/PRNewswire/ -- Calliditas's interim report for the second
quarter, April - June 2024 will be
published in Swedish and English on Tuesday 13 August 2024 at 07.00
a.m. CET.
A combined audio cast and telephone conference with the
opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée
Aguiar-Lucander and CFO Fredrik
Johansson, CMO Richard Philipson and President North America
Maria Törnsén.
The presentation will be given in English.
Link to the webcast:
https://ir.financialhearings.com/calliditas-therapeutics-q2-report-2024
To participate via conference call please register via this
link:
https://conference.financialhearings.com/teleconference/?id=50049712
After registration, you will receive a phone number and a
conference ID to log in to the conference call. Via the telephone
conference, there is an opportunity to ask oral questions.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency
of the contact persons set out above, on August 5, 2024 at 7:00
a.m. CET.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/invitation-to-the-presentation-of-calliditas-s-interim-report-january---june-2024,c4019260
The following files are available for download:
|
https://mb.cision.com/Main/16574/4019260/2928380.pdf
|
Invitation to the
presentation of Calliditas_Q2 2024 ENG
|
View original
content:https://www.prnewswire.com/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--june-2024-302214085.html
SOURCE Calliditas Therapeutics